Pascal immune to corneal biomechanics

Article

Intraocular pressure (IOP) measurements with the Pascal dynamic contour tonometer (PDCT) are relatively immune to changes in corneal biomechanics and pachymetry.

Intraocular pressure (IOP) measurements with the Pascal dynamic contour tonometer (PDCT) are relatively immune to changes in corneal biomechanics and pachymetry, according to a study published in the January issue of the American Journal of Ophthalmology.

Dr Jay Pepose and colleagues from the Pepose Vision Institute and the Washington University School of Medicine, St Louis, USA, conducted a prospective, non-randomized study to compare the preoperative and postoperative measurements of corneal biomechanical properties and IOP using Goldmann applanation tonometry (GAT), the ocular response analyser (ORA) and the PDCT in eyes undergoing myopic LASIK.

A total of 66 myopic eyes were measured for IOP before and after LASIK using the three devices in a randomized sequence. Metrics of corneal biomechanical properties were also recorded. After LASIK, there was a reduction in mean corneal pachymetry of 90.2 µm and in IOP measurements with GAT (Delta= -1.8±-2.8 mmHg; p<0.01), ORA-Goldmann (Delta= -4.6±-2.8 mmHg; p<0.01) and ORA-corneal compensated (Delta= -2.1±-2.6 mmHg; p<0.05). There was, however, no statistically significant difference between pre- and postoperative IOP measurements taken by PDCT (Delta= -0.5±-2.6 mmHg).

It was concluded that IOP measurements with PDCT are less likely to be affected by changes in corneal biomechanics and pachymetry after LASIK than if they are taken by GAT or ORA.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.